EWS-WT1 Chimeric Protein in Desmoplastic Small Round Cell Tumor is a Potent Transactivator of FGFR4

Desmoplastic small round cell tumor (DSRCT) is a rare but highly aggressive malignant neoplasm that typically involves the abdominal or pelvic peritoneum in children and young adults. This tumor is characterized by the presence of a specific EWS-WT1 fusion gene, which is the result of recurrent chromosomal translocation, t(11;22)(p13;q12). EWS encodes a putative RNA binding protein of unknown function with an N-terminal domain that mediates potent transcriptional activation when fused to heterologous DNA binding domains. WT1 is a tumor suppressor gene initially identified based on its inactivation in Wilms tumor. The chimeric proteins resulting from these chromosomal translocations usually possess gain-of-function transcriptional activities and define histologically and biologically distinct tumor types. EWS-WT1 has two isoforms of EWS-WT1(-KTS) and EWS-WT1(+KTS). Previous studies have identified several EWS-WT1(-KTS) target genes, most of which are involved in growth factor signaling. In the current study, using an exogenous EWS-WT1(-KTS) induction system along with the selection from candidates for target genes based on the microarray data, we identified fibroblast growth factor receptor 4 (FGFR4) as a potential EWS-WT1(-KTS) target and this induction accompanied with increased phosphorylation form of Akt and MAPK, suggesting a post-transcriptional modulation by EWS-WT1(-KTS). In addition, CTNNB1 was also identified as a potential EWS-WT1(-KTS) target that defines epithelial characteristics of DSRCT. Furthermore, up-regulation of CTNNB1 driven by EWS-WT1(-KTS) was independent of FGFR4 regulation. Expressions of FGFR4 and CTNNB1 in DSRCT clinical samples were confirmed by immunohistochemistry. This study provides regulatory mechanism of FGFR4 in DSRCT and also novel insights into the acquisition of epithelial characteristics in DSRCT.

[1]  R. Bentley,et al.  FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma , 2012, Clinical Cancer Research.

[2]  D. French,et al.  Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models , 2012, PloS one.

[3]  Helen X. Chen,et al.  Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors , 2012, Clinical Cancer Research.

[4]  M. Miyazaki,et al.  Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma , 2012, BMC Cancer.

[5]  L. Borsu,et al.  Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways , 2011, Clinical Cancer Research.

[6]  M. Heinrich,et al.  Gastrointestinal stromal tumours: origin and molecular oncology , 2011, Nature Reviews Cancer.

[7]  A. Ullrich,et al.  Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation , 2009, Clinical Cancer Research.

[8]  M. Ladanyi,et al.  The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene , 2009, The Journal of pathology.

[9]  K. Hotzel,et al.  Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. , 2008, Cancer research.

[10]  W. Gerald,et al.  Adenosine Transporter ENT4 Is a Direct Target of EWS/WT1 Translocation Product and Is Highly Expressed in Desmoplastic Small Round Cell Tumor , 2008, PloS one.

[11]  William Pao,et al.  Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond , 2008, Modern Pathology.

[12]  H. Werner,et al.  A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene. , 2007, Cancer letters.

[13]  M. Katoh,et al.  Cross-talk of WNT and FGF signaling pathways at GSK3ß to regulate ß-catenin and SNAIL signaling cascades , 2006, Cancer biology & therapy.

[14]  M. Ladanyi,et al.  SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma. , 2006, Cancer research.

[15]  Tsuyoshi Saito,et al.  Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma. , 2006, Human pathology.

[16]  C. Robson,et al.  Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer , 2005, British Journal of Cancer.

[17]  N. Itoh,et al.  Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.

[18]  J. Inoue,et al.  A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor. , 2003, The American journal of pathology.

[19]  W. Gerald,et al.  Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein. , 2003, Genes & development.

[20]  W. Gerald,et al.  Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. , 2002, Cancer cell.

[21]  Y. Kaneko,et al.  Establishment and Characterization of a Novel Human Desmoplastic Small Round Cell Tumor Cell Line, JN-DSRCT-1 , 2002, Laboratory Investigation.

[22]  M. Jeffers,et al.  Fibroblast growth factors in cancer: therapeutic possibilities , 2002, Expert opinion on therapeutic targets.

[23]  G. Frantz,et al.  A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. , 2002, The American journal of pathology.

[24]  H. Werner,et al.  Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein , 2002, Oncogene.

[25]  Gillian E. Wu,et al.  Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. , 2002, The Journal of clinical investigation.

[26]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[27]  D. Haber,et al.  Wilms tumor and the WT1 gene. , 2001, Experimental cell research.

[28]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[29]  J. Pelletier,et al.  The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties , 1998, Oncogene.

[30]  J. Pelletier,et al.  The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct , 1998, Oncogene.

[31]  W. Gerald,et al.  The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour , 1997, Nature Genetics.

[32]  H. Werner,et al.  The IGF-I Receptor Gene Promoter Is a Molecular Target for the Ewing's Sarcoma-Wilms' Tumor 1 Fusion Protein* , 1996, The Journal of Biological Chemistry.

[33]  W. Gerald,et al.  Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  S. Culine,et al.  Desmoplastic small round cell tumors: results of a four‐drug chemotherapy regimen in five adult patients , 1996, Cancer.

[35]  W. Gerald,et al.  Desmoplastic Small Round-Cell Tumor: A Recently Recognized Tumor Type Associated with a Unique Gene Fusion , 1995 .

[36]  W. Gerald,et al.  Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. Gerald,et al.  Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. , 1994, Cancer research.

[38]  C. Denny,et al.  The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.

[39]  J. Partanen,et al.  Amplification of fgfr4 gene in human breast and gynecological cancers , 1993, International journal of cancer.

[40]  E. Wills,et al.  Intra‐Abdominal Desmoplastic Small Round Cell Tumor , 1993, Pathology.

[41]  W. Gerald,et al.  Intra‐abdominal Desmoplastic Small Round‐Cell Tumor: Report of 19 Cases of a Distinctive Type of High‐Grade Polyphenotypic Malignancy Affecting Young Individuals , 1991, The American journal of surgical pathology.